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Background: Integrating rehabilitation services through wearable systems has the potential to accurately assess the
type, intensity, duration, and quality of movement necessary for procuring key outcome measures.
Objectives: This review aims to explore wearable accelerometry-based technology (ABT) capable of assessing
mobility-related functional activities intended for rehabilitation purposes in community settings for neurological
populations. In this review, we focus on the accuracy of ABT-based methods, types of outcome measures, and the
implementation of ABT in non-clinical settings for rehabilitation purposes.
Data sources: Cochrane, PubMed, Web of Knowledge, EMBASE, and IEEE Xplore. The search strategy covered three
main areas, namely wearable technology, rehabilitation, and setting.
Study selection: Potentially relevant studies were categorized as systems either evaluating methods or outcome
parameters.
Methods: Methodological qualities of studies were assessed by two customized checklists, depending on their
categorization and rated independently by three blinded reviewers.
Results: Twelve studies involving ABT met the eligibility criteria, of which three studies were identified as having
implemented ABT for rehabilitation purposes in non-clinical settings. From the twelve studies, seven studies
achieved high methodological quality scores. These studies were not only capable of assessing the type, quantity,
and quality measures of functional activities, but could also distinguish healthy from non-healthy subjects and/or
address disease severity levels.
Conclusion: While many studies support ABT’s potential for telerehabilitation, few actually utilized it to assess
mobility-related functional activities outside laboratory settings. To generate more appropriate outcome measures,
there is a clear need to translate research findings and novel methods into practice.
Keywords: Wearable technology, Telerehabilitation, Mobility, Accelerometers, Motion analysis, Home monitoring,
Machine learningIntroduction
A rapid increase in neurological disorders [1] has
spurred contemporary healthcare services to reorganize
themselves in response. Most neurological disorders
cause functional disabilities due to motor impairments
and physical deconditioning, giving rise to postural in-
stability, gait disturbances, increased fall risks, mobility* Correspondence: dax.steins-2011@brookes.ac.uk
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reproduction in any medium, provided the orloss, increased fatigability, and reduced independence
[2-4]. To improve individual health and well-being, re-
habilitation programs aim to reduce or restore motor im-
pairments and promote functional ability for those with
neurological disorders. As many neurological disorders
result in considerable morbidity [5], research on the effect-
iveness of neurorehabilitation for subjects with neuro-
logical disorders is of utmost importance, not only for
those with disabilities but also for caregivers, treatment
providers, policy makers, and society as a whole [6].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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barriers, for instance, inadequate policies, standards, fund-
ing, information, communication, accessibility, and re-
sources [7,8]. Studies on the integration of rehabilitation
services, new technologies, pharmaceuticals, community
exercise programs, and chronic disease management for
people with neurological impairments have the potential
to discover ways of improving outcomes while reducing
costs.
The World Health Organization framework of Inter-
national Classification of Functioning, Disability, and
Health (ICF) employs a biopsychosocial model to de-
scribe human functioning through the capture of body
function and through the individual’s activity and partici-
pation within his or her social and physical environment.
It is important to note that in the activity and participa-
tion construct, there is a distinction made between a
person's ability to perform a skill in the clinic and his or
her ability to perform that same skill in a natural envir-
onment. The measurement of function, activities, and
participation in natural environments is now possible
through microelectromechanical systems (MEMS) and
should be taken into consideration.
Nowadays, MEMS technology—particularly inertial sen-
sors that contain accelerometers, gyroscopes, and occa-
sionally magnetometers—can assess the type, intensity,
duration, frequency, and quality of various mobility-
related functional activities [9]. These sensing systems can
be used to provide telerehabilitation, that is, the option to
deliver rehabilitative services at remote sites, thereby
introducing new possibilities for continuous, unsuper-
vised, objective monitoring of mobility and functional ac-
tivities in clinical [10] and non-clinical settings [11].
Numerous systematic and non-systematic reviews on
telerehabilitation [11-15], physical activity monitoring
[16-22], and human motion analysis [10,18,22-24] exist
today. Some provide in-depth overviews of different
motion-sensing applications for gait and balance evalu-
ation, fall risk assessment, and mobility monitoring in
various populations (e.g. stroke, elderly) in clinical
[21,22] and non-clinical settings [19,20], ultimately veri-
fying the feasibility of adopting wearable motion-sensing
technology. Yet no reviews have evaluated the employ-
ment of valid motion-sensing technology capable of
assessing functional activities in home and community
settings within neurological populations. A clear under-
standing of translational research on existing motion-
sensing technology validated for the community would
provide a better grasp of what is and needs to be done
to close the gap between basic science and practice [25].
The aim of this review is therefore to explore wearable
accelerometry-based technology (ABT) capable of asses-
sing the type, quantity, and quality of mobility-related
functional activities in neurological populations in homeand community settings. It will do so by addressing the
following questions. Which sorts of accelerometry-based
methods can accurately assess functional activities? Which
types of outcome measures are suitable for obtaining qual-
ity measures of functional activities? Have these methods




Neurological disorders are categorized as major chronic
diseases [26]. Because of their immense variety, this re-
view only focuses on the most frequently occurring
chronic conditions that induce motor fluctuations and
movement disorders: Parkinson’s disease (PD), Multiple
Sclerosis (MS), stroke, Cerebral Palsy (CP), and Huntington’s
disease (HD).
MEMS technology offers various wearable motion-
sensing applications, ranging from accelerometers, gyro-
scopes, and force-sensing resistors to inertial measure-
ment units (IMUs). Because MEMS-based accelerometers
form the basis for many motion-sensing applications, this
review only considers wearable technology that contains
accelerometers—at times, in conjunction with other
MEMS applications. Accelerometers, in short, form a ne-
cessary but by no means sufficient criteria condition.
The ICF does not provide a unified definition of func-
tional activities. Neither does general literature. The ICF
does define mobility as changing (d410-d429) and main-
taining body positions (d450-d469) [27]. Functional ac-
tivities in this review denote the basic functional abilities
considered key for independent living, such as walking,
sitting, standing, and activity transitions.
Literature search
A literature search was conducted on the following elec-
tronic bibliographic databases from January 2012 to
January 2013: Cochrane (1940-2013), EMBASE (1974-
2013), PubMed (1950-2013), Web of Knowledge (1980-
2013), and IEEE Xplore (1946-2013). References from
retrieved articles were checked using the Web of Science
database. Generic search and MeSH terms for each data-
base were used to identify relevant studies (Additional
file 1: Appendix A). The search strategy was anchored
on the following three categories: telemetry and rehabili-
tation, wireless technology, and human locomotion. Lan-
guage restrictions were set. Only English studies were
included.
Study selection
Figure 1 illustrates the selection procedure used to screen
studies. For each database search, titles and abstracts were
screened by three independent reviewers (DS, JC, and PE).
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Figure 1 Procedure for the study selection and organization.
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mobility-related functional activities in neurological popu-
lations. The following exclusion criteria were used to fur-
ther identify potentially relevant studies: a) telephone
counseling interventions; b) network interventions; c) mis-
cellaneous outcome measures, such as energy expenditure
and activity behavior; d) miscellaneous technology used
for assessing functional activities, such as robotics, pe-
dometers, force-sensing resistors, virtual reality, and cue-
ing devices; e) reviews; f ) book reports; and g) off-topic
articles. Studies that provided insufficient information to
allow adequate interpretation of outcome measures and
results were also excluded.
Full-text articles were then retrieved and evaluated by
four independent reviewers (DS, HD, JC, and PE). Studies
were included if they: a) concerned neurological conditions,
b) employed wearable ABT, c) evaluated mobility character-
istics of the lower extremity through functional activities,
and d) were intended for rehabilitation purposes in home
and community settings. Motor symptoms due to neuro-
logical disorders affecting mobility (e.g. spasticity, tremor)
were additionally included in this review only if they were
integrated as an aspect of mobility through functional activ-
ity testing. In order to ensure that results across studies
were comparable, this review distinguished studies using
ABT to evaluate the aforementioned outcome measures
(mobility characteristics of functional activities) from stud-
ies proposing ABT approaches. The validation of ABT-
systems served as the final screening measure for inclusion.Assessment of methodological quality
Three authors (HD, JC, and PE) independently evaluated
the selected studies using two customized versions of
methodological criteria adapted from the PEDro scale [28]
and CONSORT [29] and Trend statements [30]. One ver-
sion was founded on ABT that evaluates outcome parame-
ters of functional activities, while the other drew upon
ABT-methods.
Both customized versions were piloted to assess the
reliability of the quality assessment process. All authors
were blinded to paper authors, affiliations, publication
dates, journals, funding sources, and references. Dis-
agreements were resolved through consensus meetings.
The next step of the quality assessment process involved
extracting information regarding the content, construction
(e.g. measurement protocols), population (e.g. population
size, reports of baseline characteristics), and measurement
properties of each system. Extracted measurement proper-
ties were: content and criterion validity. The quality of
measurement properties was determined by internal valid-
ity components (e.g. sample size) as well as external valid-
ity components (e.g. generalization). Study results needed
to be founded on statistical methods, including reports of
accuracy metrics.
Accelerometry-based outcome measures were deemed
valid if the methods were cross-validated with a “gold
standard” criterion, such as an optical motion camera
system. Going further, studies that introduced ABT-
methods based on activity classifiers or other approaches
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compared with that of suitable population-specific ques-
tionnaires (e.g. UPDRS) and/or cross-validated with ap-
propriate statistical analysis (e.g. K-fold cross-validation,
bootstrap method, leave-one-out method).
Results
Search
The initial literature search resulted in the retrieval of
1738 studies (Figure 2). After screening for relevant titles
and abstracts, then winnowing out duplicates and off-
topic studies, 522 studies remained. Most studies were
excluded on the basis that they did not involve neuro-
logical conditions (Figure 3). In other cases, when au-
thors published several studies on the same research
initiative, only their most recent studies that satisfied the
inclusion criteria were kept. After such selective factors
were applied, 14 studies remained. A reference search
on the Web of Science retrieved two more relevant stud-
ies. The now 16 studies [31-46] were categorized accord-
ing to whether they proposed ABT-methods (N = 11),
evaluated ABT-outcome measures (N = 6) able to assess
mobility characteristics of functional activities, or per-
formed a combination of both. A total of 12 studies
passed the validation screening and were finalized for
this review: nine method studies [31-34,38,39,42,43,45],
four outcome studies [33,37,40,44], in which one study
[33] straddles both categories. A total overview of in-
cluded studies can be found in Additional file 2: Appen-
dix B and Additional file 3: Appendix C.
Study quality
External and internal validity
The methodological quality scores for those studies
evaluating outcome measures for mobility-related func-
tional activities were consistently high. Scores ranged
from 10 to 12 (max 12), whereas quality scores for stud-
ies proposing ABT-methods were generally lower, ran-
ging from 4 to 9 (max 13; Tables 1 and 2).
Studies evaluating outcome measures of mobility-
related functional activities largely involved stroke (n =
3) [33,37,40] and PD (n = 1) [44]. Stroke studies showed
great diversity in study design, population demographics
(e.g. population size, disease onset), and methodology.
They consisted of pilot studies (n = 2) [33,44], one cross-
sectional study [37], and one experimental study [40].
Across the stroke studies, age range was fairly compar-
able. Population demographics, conversely, were not
comparable between studies, because of insufficient in-
formation. Most studies used a control group (n = 3)
[30,34,41], of which only one adopted an age-matched
control group [44]. System measurement properties were
determined through internal validity components, which
were stopwatch measures [33], optical motion-sensingsystems [34,41], or footswitches [40]. Outcome measures
were reasonably similar, mainly focusing on correlation
and accuracy levels.
Studies evaluating ABT-methods were mainly PD
studies (n = 6) [31,32,38,42,43,45] and, to a lesser extent,
stroke (n = 3) [33,34,39]. None involved other neuro-
logical conditions. PD and stroke method studies were
all based on experimental study designs with small
population groups (n ≤ 10), minus two PD studies
[28,29], which recruited testing groups of 20 subjects or
more. Between stroke studies, the population age ranged
widely (45-68 years). Some studies were conducted with-
out a control group altogether [34,39]. None featured an
age-matched control group [33]. The report of baseline
characteristics and eligibility criteria revealed much di-
versity in medication treatment, disease onset, and dis-
ease severity (e.g. UPDRS scores), whether or not
patients were sensitive to deep brain stimulation and ex-
perienced motor fluctuations. The measurement proper-
ties used to determine validity were primarily based on
external validity components cross-validated with video
recordings [35,40] and statistical methods, such as K-
fold cross-validation [31,34]. Three studies employed a
combination of internal and external validation proce-
dures [29,39,42].
All studies demonstrated notable variation in terms of
methodology, study design, population demographics,
and outcome measures, making it difficult to evaluate
study results, which subsequently made a meta-analysis
unfeasible. For ease of reading, the results will be
chronologically described according to the stated aims of
this review.
Accelerometry-based methods able to accurately assess
functional activities
The term “accuracy” was applied in two ways. Firstly, it
was used to describe if ABT-methods were able to dis-
tinguish healthy from non-healthy subjects and assess
disease severity levels. Secondly, the term was used to
signify the precision of reported metrics.
As previously mentioned, nine studies [31-34,38,39,42,43,45],
consisting of six PD studies [31,32,38,42,43,45] and
three stroke studies [33,34,39], proposed valid accelerometry-
based methods able to identify mobility-related func-
tional activities. These methods were founded on various
machine-learning classifiers (e.g. decision trees, support
vector machines [SVM]) [31-34,42,45], algorithms [38,43],
and gait cycle parameters [39]. Table 3 provides a detailed
overview of the different methodological approaches used
to determine the types of functional activities and their
capabilities.
Parkinson disease Classifiers. Four out of the six PD
studies [28,29,39,42] employed machine-learning classifiers.
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73 full-text studies screened by three researchers 
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Aim 1:
Which ABT-methods can accurately assess functional activities?
Aim 2:
Which types of ABT-outcome measures are suitable of obtaining 
quality measures of mobility?
Aim 3:
Have these ABT-systems/methods been implemented in home and 
community settings?
Figure 2 Flowchart of the results from the literature search.
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tory activities [31,32,45] and other functional activities (e.g.
sitting, standing [32,45]). The remaining study used its ac-
tivity classifier to detect sit-to-stand (STS) transitions from
non-transitions [42]. From these four studies, Barth et al.[31] and Cancela et al. [32] evaluated various activity classi-
fiers. Barth et al. [31] evaluated the following activity classi-
fiers to detect gait patterns able to distinguish healthy
controls from PD patients and mild gait impairments from








Figure 3 Piechart of the screening results from the literature search. Studies are divided in: (A) motion-sensing technology to assess
functional activities in neurological or non neurological conditions; (B) type of neurological conditions; (C) technology intended for rehabilitation
purposes; and (D) type of technology.
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SVM with linear and Radial Basis Function (RBF) kernel.
The accuracy of their sensor system was based on three ac-
tivities from the UPDRS (Part III), namely 10 m walking,
heel-toe tapping, and foot circling. The LDA classifier
achieved the best overall accuracy, classifying patients and
controls with a sensitivity of 88% and specificity of 86%.
When optimized for the most accurate features, it reached
a 100% sensitivity and specificity. The most optimal features
were derived from step features (step duration), signal se-
quence (entropy [47], variance), and frequency analysis(energy ratio and 0.5-3 Hz energy band). Cancela et al. [32],
on the other hand, used six different activity classifiers (i.e.
k-nearest neighbour [kNN], Parzen, Parzen density, Binary
decision tree, feed-forward neural network [Bpxnc],
SVM) to automatically detect the severity of walking-
derived bradykinesia according to UPDRS scores. The
SVM classifier related the best to the UPDRS output
scores by clinicians, with an accuracy range between
70 and 86% (i.e. sensitivity), using two statistical fea-
tures (root mean square values and range) over a 5 s
interval with 50% overlap.








et al [37]Customized scale items
External validity
1. Eligibility criteria specified 1 1 0 1
Internal validity
2. Baseline characteristics described 1 1 1 1
3. Measurement protocol clearly described 1 1 1 1
4. Measurement procedure is clearly described for each group to allow replication 1 1 1 1
5. Completely defined pre-specified outcome measures 1 1 1 1
6. Outcome measures are reliable and valid 1 1 1 1
7. Statistical methods used to compare groups outcomes 1 1 1 1
8. Between-group statistical comparisons are reported for at least one outcome 1 1 1 1
9. The study provides measures of variability for at least one outcome 1 1 1 1
10. Methods for additional analyses, such as subgroup analyses and adjusted analyses 0 0 1 1
11. Reported trial limitations 0 1 1 1
12. Interpretation of the results 1 1 1 1
Total score 10 11 11 12
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also, like Zwartjes et al. [45], assessed symptom severity
levels in PD as part of their detection process. Zwartjes
et al. [45] employed a decision tree for a complete motor
assessment by simultaneously analyzing various functional
activities and symptom severity (i.e. tremor, bradykinesia,






et alCustomized scale items
Internal validity method
1. Baseline characteristics described 0 1 0
2. System and devices are clearly described 1 1 0
3. Measurement protocol is clearly described
for each group to allow replication
1 0 1
4. Methods of analysis clearly described 1 1 1
5. Classifier(s) are evaluated 1 n/a 0
6. Statistical methods used to test reproducibility 1 0 1
7. Reported accuracy metrics 1 0 1
8. Reported confidence intervals for classifier
performance
0 n/a 0
9. Study limitations described 0 0 1
10. Interpretation of the results 0 0 1
Construct validity method
11. Content validity 1 0 148
12. Criterion-related validity is obtained 1 1 0
13. Cross-validation (i.e. test and training set) 1 0 1
Total score 9 4 8with an overall accuracy of 99.3%. The motor assessment
was mainly founded on UPDRS-items (Part III), including
foot-tapping and several daily activities. Their PD monitor
correlated well with the UPDRS and could, thus far, detect
significant changes in rest and kinetic tremor, with an ac-
















1 1 0 0 1 1
1 1 1 1 1 1
1 1 1 0 1 1
1 1 1 1 1 1
1 1 n/a 1 n/a 0
1 1 0 0 0 1
1 1 0 0 0 0
0 0 n/a 0 n/a 0
0 0 1 0 0 0
0 1 1 0 1 1
0 0 0 1 0 0
1 0 1 0 1 1
1 1 0 0 0 0
9 8 6 5 6 7
Table 3 Overview of accelerometry-based methods
Authors Population Method Validity Quality Quantity Activity
Lau et al [34] Stroke SVM, MLP, RBF Leave-one-subject-
out method
- - Walking
Barth et al [31] PD Boosting with decision stump as
weak learner, LDA, and SVM with
linear and RBF kernel
Leave-one-subject-
out method
x x Walking, foot circling,
and heel-toe tapping
Cancela et al [32] PD kNN, Parzen, Parzen density, binary
decision tree, Bpxnc train NN by
back-propagation, and SVM
Cross-validation x - Daily activities (i.e. walking,
lying, sitting, drinking a
glass of water, opening and
closing a door)
Salarian et al [32] PD Logic Regression model with Mamdani
fuzzy rule-based classifier
Cross-validation - x sit-to-stand and stand-to-sit
Zwartjes et al [45] PD Decision tree Leave-one-subject-
out method
x - lying, sitting, standing,
and walking
Yang et al [43] PD Autocorrelation method Video recordings - x Walking
Motoi et al [39] Stroke Sagittal angle changes - - Walking and sit-to-stand
Moore et al [38] PD Mathematical step-length algorithm Pen techniques and
video recordings
x x Walking
Dobkin et al [33] Stroke Naive Bayes classifier in combination
with Gaussian discretization followed
by a maximum likelihood estimation
Stopwatch - x Walking
Abbreviations: LDA Linear Discriminant Analysis, SVM Support Vector Machines, RBF radial basis function neural network, K-NN K-nearest neighbour, NN Neural Net-
work, MLP multi-layer perception; Quality, methods assessing severity levels, Quantity, methods able to distinguish healthy from non-healthy subjects.
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tivity classifier to categorize STS transitions. Able to separ-
ate transitions from non-transitions and differentiate
between sit-to-stand and stand-to-sit with a sensitivity of
83.8% in PD and 94.4% in healthy controls, their method
used a mamdani fuzzy rule-based classifier in tandem with
two statistical classifiers based on a generalized logistic re-
gression model. Acceleration and tilt measures of the
trunk, previously described by Najafa [48,49], were used to
detect transitions. Salarian’s method [42] has been inte-
grated into the iTUG (instrumented Timed-Up and Go
Test) [44,50], which also contains a 180° turn analyzing
algorithm [51].
The two other PD studies [38,43] based their method on
algorithms. Yang et al. [43] validated an autocorrelation
function of the vertical acceleration for possible real-time
analysis of disabling PD gaits for ambulatory rehabilita-
tion, gait assessments, and motor fluctuations. Moore
et al. [38], conversely, developed a validated stride length
algorithm able to accurately estimate stride lengths of
healthy and PD subjects in their natural environment. The
ensuing stride length measures exhibited a linear relation-
ship to the actual stride length (r = .98) and obtained an
improved accuracy (mean error ± 0.05 m) relative to previ-
ous techniques utilized [52,53]. In a follow-up study, the
capabilities of the stride length monitor were extended
with the detection of freezing events in PD [54].
Stroke Classifiers. Two out of three stroke studies
[33,34] employed machine-learning classifiers for thedetection of ambulatory activities, whereas the remaining
stroke study assessed functional activities through angle
measurements [39].
In presenting a possible tool for pathological gait ana-
lysis, pattern recognition, and activity monitoring, Lau
et al. [34] explored the performance of various classifiers
(i.e. SVM, artificial neural network [ANN], RBF, Bayesian
belief network [BBN]) in different walking conditions (i.e.
level ground, stair ascent, stair descent, upslope, down-
slope) for stroke subjects with dropped foot. The SVM
proved superior to other classifiers, achieving an overall
accuracy of 92.9% to 96.8% for both groups and individ-
uals. In addition, it distinguished stair ascent and descent
from other conditions with 100% accuracy and classified
all five conditions with 84% accuracy.
Dobkin et al. [33] successfully implemented a naive Bayes
method to estimate the walking speed of stroke patients in
home and community settings. Feature selection was based
on time domain data (e.g. dominant frequencies, ampli-
tudes, waveforms of acceleration, signal derivatives) that
was converted into vector form. The estimation of outdoor
walking speeds highly correlated with stopwatch-measured
speeds (r = .98; p = .001), including repeated measures
(p = .01).
Unlike the two studies above, Motoi et al. [39] pre-
sented a gait and STS analyzing method based on angle
and acceleration patterns to determine the level of long-
term care. Noticeable angle changes and fluctuations of
the trunk, thigh, and knee were detected between differ-
ent severity and care levels.
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measures of functional activities
Research on the effectiveness of neurorehabilitation is of
upmost importance and necessitates the determination of
appropriate outcome measures beforehand. Four out of
six studies [33,37,40,44] (three stroke studies [33,37,40],
one PD study [44]) passed the eligibility criteria (§2.3) and
were categorized as valid (Table 4).
Stroke
Walking speed is generally considered to be a significant,
sensitive, and reliable marker of deficit severity and
walking ability [55]. With this understanding in mind,
Dobkin et al. [33] and Prajapati et al. [40] both affirmed
walking speed as a sensitive outcome measure able to
evaluate the effect of rehabilitation on movement quality
and stroke severity indices. Dobkin et al. [33] found
walking speed could be related to stroke severity and re-
covery, where patients who walked faster than 0.8 m/s
could reach higher speeds under different walking condi-
tions than those who walked below 0.8 m/s. Prajapati
et al. [40] more or less confirmed this observation by
finding a correlation between walking speed, balance im-
pairment as measured by the Berg Balance Scale [56]
(r = .60; p < .013), and walking period (r = .51; p = .045).
Mizuike et al. [37] proposed a different outcome meas-
ure, an acceleration-derived one, normalizing root mean
square (nRMS) values of acceleration to forge a new
measure by which to evaluate gait characteristics and
form an index of treatment outcomes for rehabilitation.
The values of the nRMS may serve as an indicator for
the dynamics of walking patterns, reflecting motor re-
covery and gait abilities. nRMS values were also able to dis-
criminate between groups (p < .01) and several Brunnstrom
Stages (III-V, IV-V, p < .05).
Parkinson’s disease
Previous studies on the performance of the iTUG by
Zampieri et al. [57] and Salarian et al. [50] determined
sensitive outcome measures that formed the basis for
the home feasibility study conducted by Zampieri et al.Table 4 Overview of accelerometry-based outcome measures
Authors Population Outcome parameters
Dobkin et al. [33] Stroke Walking speed, bouts of walking, gait sym
Zampieri et al. [44] PD Stride length, stride velocity, cadence, pe
swing velocity on the MAS, and turning
Mizuike et al. [37] Stroke Accelerometers derivatives, raw RMS, no
RMS, autocorrelation function
Prajapati et al. [40] Stroke Walking bouts, total walking time, gait sp
number of steps, gait symmetry, swing s
cadence
Abbreviations: MAS most affected side; Quality, studies assessing severity levels; Qua[44]. Peak arm swing velocity on the most affected side,
average turning velocity, cadence, and peak trunk rota-
tion were significantly slower in PD than control sub-
jects and may potentially be used to detect disease
progression and patient response to symptomatic and
disease-modifying treatments. It is to be noted that the
iTUG’s STS components (e.g. duration, range of motion,
angular velocity) were the least reliable, whereas walking
and turning components (e.g. stride length and velocity,
cadence, peak arm swing velocity, turning velocity) were
the most reliable. When assessed at home, Zampieri et al.
[44] demonstrated that from the aforementioned outcome
measures, stride velocity (p = .02) and length (p = .002) af-
fected PD subjects significantly, resulting in slower and
shorter steps.
Accelerometry-based technology implemented in non-
clinical settings
From this review’s twelve featured studies, only three
[33,38,44] actually took measurements in both clinical
and non-clinical environments. Two out of these three
studies, both incidentally dealing with stroke, proposed
ambulatory activity pattern estimations, one for stride
length [38] and the other for walking speed [33]. The
remaining study by Zampieri et al. [44], a PD one, inves-
tigated the possibility of implementing the iTUG in
home environments. It was the only study in this review
to broach this subject.
Results for remaining neurological studies were only
garnered through clinical assessments carried out at hos-
pitals or laboratory environments. Although all studies
were intended for telerehabilitation purposes, only Salarian
et al.’s [42] and Motoi et al.’s [39] methodological studies
helped pave the way for their other studies that examined
the implementation of MEMS-based accelerometers in
non-clinical settings.
Discussion
Application of ABT in neurological populations
Search results indicate that a vast amount of literature
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activities. Only 22.2% of studies mentioned, however, use
ABT in neurological populations. Only 9.7% of these tar-
geted studies, in turn, are intended for rehabilitative pur-
poses in non-clinical settings. Of this last group, the
majority of studies focus on the classification and quantifi-
cation of ambulatory activities in Parkinson or stroke survi-
vors, excluding subjects coping with other neurological
diseases. The quantification of mobility-related functional
activities—walking, in particular—generates much infor-
mation on a patient’s physical capabilities, recovery, and
activity behavior. But it is ill-equipped to address the
qualitative measures of an individual’s exercise perform-
ance, inevitably omitting those details clinicians require to
adapt therapies and medications to individual needs.
Although this review has identified a few studies that
evaluate outcome measures able to address rehabilita-
tion’s impact on movement quality, the primary chal-
lenge still remains: how can more appropriate outcome
measures be established, those more useful in determin-
ing each severity stage’s movement quality? While the
main focus of this review lies in the accurate classifica-
tion of various functional activities, future research
would ideally analyze these activities beyond the scope
of step counts and duration.
Accuracy of ABT-methods
The number of studies (N = 12) that covers the measure-
ment properties around reliability, validity, and respon-
siveness of accelerometry-based systems in neurological
populations remains relatively low. Those methodological
studies included that cover measurement properties may,
in some cases, be compromised in terms of sample size.
For those studies proposing methods based on activity clas-
sifiers [31-34,42], sample sizes range from 5 to 27 subjects.
Such numbers are usually too small to generalize accuracy
levels. Two out of such activity classifier-based studies,
moreover, lacked a control group [32,34]. It is therefore im-
portant to evaluate activity classifier performance according
to larger, homogeneous population sets that include an
equal number of healthy and non-healthy participants [58].
How effective or well-performing a classifier is not only
depends on its overarching study design, but also on the
selected features and ABT accuracy. In general, difficulties
evaluating a particular classifier’s success or failure stems
from the relative silence regarding the feature extraction
process, which depends on the analysis of movement pat-
terns [59]. How ABT plays into classifier performance re-
mains less obscure because well-canvassed in comparison
to feature extraction. While generally considered to be an
easy-to-use and inexpensive type of technology, ABT is
prone to offset fluctuations, sensor noise, and estimation
errors, which lead to integration drift [60]. Integrating a
Kalman filter with received signal strength indicator(RSSI) measurements can drastically reduce this drift, in-
creasing overall accuracy [61,62]. Blumrosen et al. [62]
have recently assessed the feasibility of employing RSSI in
coordination with ABT for body tracking and feature ex-
traction purposes, establishing various criteria and analyt-
ical methods to facilitate this end. Although this type of
technology is a future option for telerehabilitation, it is be-
yond the scope of this review.
Most studies wielding ABT in neurological populations
for remote rehabilitation employ various machine-learning
classifiers covering different aspects of neurorehabilitation,
ranging from activity classification and symptom severity
level assessment to long-term activity monitoring. While
the question of which classifier is ideal for remote moni-
toring naturally follows, it currently cannot be addressed
due to scant research in the field of telerehabilitation. This
review did, however, identify studies that cross-examine
the performance of different activity classifiers and their
feature selections [31,32,34]. The SVM, LDA, and decision
tree seem to perform better than their counterparts. The
SVM, it must be added, was presented in the top ten most
influential machine-learning algorithms [58].
Potential of ABT in non-clinical settings
In the process of gathering studies deploying ABT
intended for rehabilitation purposes in non-clinical set-
tings, this review identifies several promising studies
[33,44,45]. Dobkin et al. [33] presents a pilot study that
grounds its feature extraction on a naive Bayes method
in a Medical Daily Activity Wireless Network [9,63]. Its
machine-learning algorithm can not only identify, quan-
tify, and qualify different activities, but also assess pa-
tient’s activity behavior during the day. Naive Bayes (or
simply "Bayes") is easy to construct and can be readily
applied to large data sets, as the method does not need
any complicated iterative parameter estimation schemes.
In terms of assessing mobility deficits in patients with
early to mid PD, Zampieri et al. [44] successfully tests
the feasibility of assessing the iTUG in home environ-
ments. Several papers [50,51,57] have contributed to this
approach, including Salarian’s feature extraction paper
on STS transitions [42]. Their method can not only dis-
tinguish between PD and healthy subjects, but also be-
tween “on” and “off” conditions in PD subjects. In terms
of feature selection, their feature sets correlate reason-
ably well with the UPDRS, indicating that severity levels
can potentially be judged and monitored.
Exploring this potential, Zwartjes et al. [45] actually clas-
sify PD symptoms in various functional activities and their
severity, correlating their ABT method with UPDRS
scores (e.g. tremor r = .87, p < .01) in line with other stud-
ies [64,65]. Strikingly enough, their PD monitor detects
changes between different conditions of brain stimulation,
whereas the UPDRS did not. The UPDRS is the most
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ity and has excellent test-retest reliability for motor scores
(ICC 0.90), but achieves only moderate to good reliability
for symptom-based scales (ICC 0.69 - 0.88) [66]. That an
ABT-based PD monitor not only correlates well with the
UPDRS, but also allows for more sensitive readings of PD
symptoms renders it an attractive measurement tool to as-
sist the UPDRS.
So far, MEMS-based accelerometers, embedded with
machine-learning algorithms, are deemed able to accurately
assess various mobility-related functional activities and dis-
ease symptom severity levels. Yet the effectiveness of ABT
in home-based rehabilitation regimens still has to be further
examined. Zampieri et al. [44] most relevantly addresses
such questions, drawing out significant links (e.g. testing lo-
cation influences stride length and velocity). Whether the
iTUG can easily be administered in non-clinical settings
without supervision, in particular, remains a pressing issue,
as the device requires proper set-up before tests.
Limitations
The original database search included MesH terms of spe-
cific neurological diseases, which prevented a significant
number of engineering articles from being considered due
to their indexing method. That the IEEE Xplore database
only permitted limited search term bindings posed an add-
itional hurdle to widening the review’s scope. A broader
search strategy was implemented at this stage, one elimin-
ating neurological terms while still covering only those
studies surrounding the use of wearable ABT for rehabili-
tation purposes. More relevant studies were consequently
extracted. Many articles, especially engineering ones, did
not provide clear or complete titles, abstracts, or research
contexts with which to discern their relevance at first
glance. Full texts often fared no better, giving rise to inter-
pretative problems on multiple levels (e.g. methodology,
intervention). Such hermeneutic struggles rendered the
search to find eligible articles more difficult.
Because of the broad search strategy, strict eligibility
criteria were implemented, weeding out seemingly rele-
vant studies [54,64,67,68] from being reviewed. The only
validated studies that qualified for review related to PD
and stroke, all analyzing movement patterns of different
functional activities, with an emphasis on quantitative
and qualitative outcomes. No validated studies around
other neurological diseases were identified.
Conclusion
This systematic review focuses and clarifies the degree to
which accelerometry-based motion-sensing technologies
have been successfully implemented in the field of telereh-
abilitation. Extending and revising the insights set forward
by Bonato et al. [69] and Patel et al. [15], among other
studies, this review surveys today’s employment of ABT inneurological populations and draws out its limitations
within telerehabilitative contexts heretofore unaddressed.
By thoroughly and meticulously sifting through 1738 arti-
cles and identifying the few that actually utilize ABT-
methods capable of remotely assessing functional activities
in neurological populations, it assists researchers in mak-
ing informed, time-sensitive decisions regarding which
current methods to use in target populations and why. In
this case, only twelve studies were determined to reliably
assess functional activities in neurological populations, of
which only three implemented ABT in home environ-
ments. As small as this number appears, it is a hard-won
indication of the need for more versatile research that
adopts or improves current ABT-methods in various
populations. Dobkin et al. [9] point out how extensive
research has been undertaken within engineering—initia-
tives that, bolstered by current advances in MEMS tech-
nology, are slowly fulfilling demands in telerehabilitation
and telemedicine. As this review emphasizes, however,
clinical and real-world research significantly lags behind
its engineering counterpart.
The main challenges facing the deployment of ABT rest
in: a) the difficulty in homogenizing a range of distinct re-
search methods and features to realize the same aims, b)
the use of appropriate outcome measures for movement
quality assessments, and c) the lack of awareness sur-
rounding ABT’s clinical usefulness. In order to address
such challenges, research should keep the following three
initiatives in mind. Firstly, research should set analyzing
standards in different target populations, thereby allowing
researchers to better justify any potential deviations from
existing methods. Secondly, research should aim to em-
ploy appropriate outcome measures in order to obtain
qualitative movement features. Researchers can distin-
guish healthy from non-healthy subjects and classify func-
tional activities and symptom severity levels with relatively
high accuracy, but hardly explore the qualitative dimen-
sion of motor performance. The ability to assess patient
movement in clinical and non-clinical settings would per-
mit researchers, clinicians, and caretakers within the areas
of prevention, diagnostics, disease progression, telerehabil-
itation, and telemedicine to improve individual health and
well-being with greater nuance. Thirdly, follow-up studies
should incorporate a multidisciplinary approach, with
their research findings translated for a wider audience and
ABT’s clinical practicality directly promoted as a result.
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